← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2025-02-28

Drug application

FDA Application #

NDA218475

Application type

New Drug Application

Brand name

EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

Generic name

EPINEPHRINE

Active ingredients

EPINEPHRINE BITARTRATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2025-02-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown